Gerd Michel
About
In The Last Decade
Gerd Michel
61 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 101
- Epidemiology 822
- Hepatology 646
- Infectious Diseases 374
- Molecular Biology 344
- Cardiology and Cardiovascular Medicine 163
Countries citing papers authored by Gerd Michel
This map shows the geographic impact of Gerd Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Michel more than expected).
Fields of papers citing papers by Gerd Michel
This network shows the impact of papers produced by Gerd Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Michel. The network helps show where Gerd Michel may publish in the future.
Co-authorship network of co-authors of Gerd Michel
This figure shows the co-authorship network connecting the top 25 collaborators of Gerd Michel. A scholar is included among the top collaborators of Gerd Michel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerd Michel. Gerd Michel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 52 | |
| 3 | 25 | |
| 4 | 4 | |
| 5 | DETERMINATION OF HOMOCYSTEINE REFERENCE INTERVALS: DATA FROM THE EUROPEAN AUTOMATED FPIA STUDY | 1 |
| 6 | 13 | |
| 7 | 22 | |
| 8 | 6 | |
| 9 | 15 | |
| 10 | 25 | |
| 11 | 12 | |
| 12 | 61 | |
| 13 | 16 | |
| 14 | GOR-antibodies in patients with chronic liver disease and hepatocellular carcinoma. | 1 |
| 15 | 31 | |
| 16 | 7 | |
| 17 | 14 | |
| 18 | 58 | |
| 19 | 10 | |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.